The effects of early short-term insulin treatment vs. glimepiride on beta cell function in newly diagnosed type 2 diabetes with HbA1c above 9.
Jelena StojanovicMarina Andjelic-JelicMiljanka VuksanovicMilica Marjanovic-PetkovicBiljana JojicMarko StojanovicTeodora Beljic-ZivkovicPublished in: Turkish journal of medical sciences (2023)
Early short-term insulin intervention in newly diagnosed T2D improves beta cell function more than glimepiride, both added to metformin, resulting in a superior and longer lasting glycemic and lipid control.